Back to top

Risk stratification tools to identify patients with advanced COPD

Risk stratification tools to identify patients with advanced COPD in primary care

What we are doing:

We will use health data about patients with chronic obstructive pulmonary disease (COPD) that is already recorded by GP practices in Leicester, Leicestershire and Rutland (LLR) to help local health organisations work out the health needs of the local population. We will use this information to find out how many patients with advanced COPD are living in LLR and how best to predict their future needs for healthcare.

Why are we doing it:

COPD is an important cause of long term ill health in the UK and worldwide. More advanced COPD often requires admission to hospital and may become sufficiently complex to require management by hospital specialists. However, we do not know what measurements best assess the severity of COPD and how to use these measurements to determine how many patients have advanced disease in LLR. In addition, we know that patients with COPD often have other medical problems (known as multi-morbidities), which affect their health, life expectancy and are more at risk of being admitted to hospital.

What the benefits will be:

The project will help us understand how multi-morbidity affects the health of people with COPD. It will also help local health organisations to plan care for people with COPD and help local GPs to look after patients with COPD who are registered with them.

Who we are working with:

Participating stakeholders in this project include:

  • Leicester City, West Leicester and East Leicester Clinical Commissioning groups
  • University Hospitals of Leicester NHS Trust
  • Arden and Greater East Midlands Commissioning Support Unit (GEM CSU)
  • Leicester Respiratory Biomedical Research Unit

Study lead:

Professor Michael Steiner, Consultant Respiratory Physician and Honorary Clinical Professor, University Hospitals of Leicester NHS Trust


Professor Michael Steiner,